Ad is loading...
DBMAX
Price
$26.45
Change
-$0.67 (-2.47%)
Updated
Nov 15 closing price
PAMCX
Price
$103.77
Change
-$2.05 (-1.94%)
Updated
Nov 15 closing price
Ad is loading...

DBMAX vs PAMCX

Header iconDBMAX vs PAMCX Comparison
Open Charts DBMAX vs PAMCXBanner chart's image
BNY Mellon Sm/Md Cp Gr A
Price$26.45
Change-$0.67 (-2.47%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Adv
Price$103.77
Change-$2.05 (-1.94%)
VolumeN/A
CapitalizationN/A
DBMAX vs PAMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBMAX vs. PAMCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMAX is a Buy and PAMCX is a StrongSell.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31B vs. DBMAX (1.27B). DBMAX (0.00) and PAMCX (0.00) have matching dividends . DBMAX was incepted earlier than PAMCX: DBMAX (16 years) vs PAMCX (25 years). DBMAX is a more actively managed with annual turnover of: 36.02 vs. PAMCX (21.70). DBMAX has a lower initial minimum investment than PAMCX: DBMAX (1000) vs PAMCX (2500). DBMAX annual gain was more profitable for investors over the last year : 22.68 vs. PAMCX (13.67). DBMAX return over 5 years is better than : 16.21 vs. PAMCX (11.07).
DBMAXPAMCXDBMAX / PAMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years25 years-
Gain YTD6.5679.22071%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B31B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year22.6813.67166%
Returns for 3 years-32.63-19.72165%
Returns for 5 years16.2111.07146%
Returns for 10 years44.4631.11143%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.830.21
+1.66%
Viatris
DX12.420.04
+0.32%
Dynex Capital
GO17.82-0.29
-1.60%
Grocery Outlet Holding Corp
ADXN8.06-0.14
-1.71%
Addex Therapeutics Ltd
ATOS1.28-0.09
-6.57%
Atossa Therapeutics